Study title:
Rosenthal-J, Arush-M-W-B, Kuten-A, Arie-J-B, Shahar-M-B, Robinson-E.
Pediatric Oncology Unit, Rambam Medical Center, Haifa 31096, Israel.
Hodgkin's disease in childhood: Treatment modalities, outcome and epidemiological aspects: The Northern Israel Cancer Center experience.
American Journal of Pediatric Hematology/Oncology {AM-J-PEDIATR-
HEMATOL-ONCOL}, 1994, Vol/Iss/Pg. 16/2 (138-142), ISSN: 0192-8562.Rosenthal-J, Arush-M-W-B, Kuten-A, Arie-J-B, Shahar-M-B, Robinson-E.
Pediatric Oncology Unit, Rambam Medical Center, Haifa 31096, Israel.
Hodgkin's disease in childhood: Treatment modalities, outcome and epidemiological aspects: The Northern Israel Cancer Center experience.
American Journal of Pediatric Hematology/Oncology {AM-J-PEDIATR-
HEMATOL-ONC...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|